In 2003, by using another anti-MCAM mAb, AA98, inhibition and reduction of blood vessel density in xenografted mice injected with human hepatocarcinoma, leiomyosarcoma, and pancreatic cancer were achieved [169]. Here, MCAM is linked to familial pancreatic carcinoma.